Statin Use and Cardiovascular Health

Benefits and Risks

The USPSTF found no clear evidence of decreased cognitive function associated with statin use, with multiple high-quality guidelines consistently reporting no evidence linking statin use to cognitive decline or dementia 1, 2, 3, 4, 5, 6, 7
Statin therapy is associated with a significant reduction in vascular events, with a meta-analysis of 13 randomized statin trials showing that for every 255 patients treated with statins for 4 years, 5.4 vascular events were prevented and only 1 additional case of diabetes occurred 1, 2, 3, 8, 9
Rare idiosyncratic cognitive reactions may occur with statin therapy, and clinicians should consider temporary discontinuation if a patient reports new cognitive symptoms while on statins 2, 4, 5
Statins are associated with a modest increased risk of new-onset diabetes, with a meta-analysis of 13 randomized trials showing an odds ratio of 1.09 for new diabetes diagnosis, but the cardiovascular benefits outweigh this risk 2, 9

The American Diabetes Association, American Heart Association, and American College of Cardiology recommend assessing cardiovascular risk using established guidelines and not withholding statins due to concerns about dementia, with the USPSTF recommending initiating low- to moderate-dose statins for adults aged 40-75 years with CVD risk factors and a calculated 10-year CVD event risk of ≥10% (Grade B recommendation) 2, 3, 7
For patients requiring lipid-lowering therapy, follow established cardiovascular guidelines for statin therapy, and for patients with diabetes or at risk for diabetes, proceed with statin therapy when indicated for cardiovascular risk reduction, consider using moderate-intensity statins in those at highest risk for diabetes, and monitor for new-onset diabetes but recognize the CV benefit outweighs this risk 2
The American Association for the Study of Liver Diseases guidelines recommend that it is safe to use statins in stable chronic liver disease, including NAFLD/NASH, monitor liver enzymes as clinically indicated, and avoid in decompensated cirrhosis or acute liver injury 10, 11, 12, 13

If adverse effects occur, consider temporary discontinuation and rechallenge for cognitive symptoms, dose reduction or alternative statin for liver enzyme elevations, and continue statin unless contraindicated and manage diabetes according to standard guidelines 2
The American College of Cardiology and other guideline societies continue to prescribe statins according to established cardiovascular guidelines, weighing the cardiovascular benefits of statins against any potential cognitive risks, and considering the use of statins to help achieve quality of life and avoid disability in elderly patients (65-75 years) by preventing cardiovascular events 14, 5